GEN Exclusives

More »

GEN News Highlights

More »
May 3, 2007

Amylin Selects Ohio as Site for Expansion of Production Plant

  • Amylin is increasing construction at the manufacturing facility in West Chester, OH, to increase investment to a total of approximately $400 million.

    The company is expanding its existing production plant near the Union Center Boulevard district, which is now in the process of being equipped to manufacture it long-acting release (LAR) formulation of exenatide, a compound in development for type 2 diabetes.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Value-Pricing Cancer Drugs

Do you think all new cancer drugs awaiting approval should undergo value-pricing?

More »